• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Mechanisms causing chromosomal translocation and its biological consequence in multiple myeloma

Research Project

Project/Area Number 13671072
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Hematology
Research InstitutionNagoya City University

Principal Investigator

IIDA Shinsuke  Nagoya City University, Graduate School of Medical Sciences, Assistant Professor, 大学院・医学研究科, 講師 (50295614)

Project Period (FY) 2001 – 2003
Project Status Completed (Fiscal Year 2003)
Budget Amount *help
¥4,100,000 (Direct Cost: ¥4,100,000)
Fiscal Year 2003: ¥1,200,000 (Direct Cost: ¥1,200,000)
Fiscal Year 2002: ¥1,200,000 (Direct Cost: ¥1,200,000)
Fiscal Year 2001: ¥1,700,000 (Direct Cost: ¥1,700,000)
Keywordsmultiple myeloma / chromosomal translocation / MUM1 / IRF4 / MAFB / transcription factor / target gene / MIG / non-homologous end joining / BOB.1 / Pou2AF1 / Non homologens end joining / Multiple Myeloma / Double strand break repair gene / Pou2A1 / Ku80 / 染色体不安定性
Research Abstract

1.Establishment of the MUM1 transgenic mice : An Eμ-SV-MUM1-myc tag-hGH construct was used for establishing transgenic mice in mature B-cells. During a long-term follow-up, no B-cell malignancy has developed in this experimental system.
2.Identification of the target genes regulated by MUM1/IRF4 and by MAFB, which are deregulated in multiple myeloma : a)MUM1 : MUM1-expressing mouse proB-cell line, BaF3, grew faster than its parent cells, suggesting that MUM1 provides the B-cells with a growth advantage by regulating its downstream target genes. By means of cDNA array analysis, we identified monokine induced by IFNγ(Mig) as one of the directly regulated genes by MUM1. A reporter assay using Mig gene promoter sequences has resulted in the elevated luciferase activity when transfected with MUM1 together with PU.1, indicating their cooperation in terms of Mig transcription. MUM1 also directly binds to Mig promoter sequences, proven by chromosome immunoprecipitation assay. Interestingly, MUM1-positive B-cell chronic lymphocytic leukemia cells also expressed Mig and its receptor, CXCR3, and neutralizing anti-CXCR3 or anti-Mig antibodies partially inhibited their proliferation, suggesting that Mig and CXCR3 constitute an which is a downstream executer of the Phosphatidyl inositol 3 kinase-Akt signaling, is positively regulated by MAFB. Ectopic expression of the ARK5 resulted in the resistance against hypo-nutritional condition and in the promoted adhesion to fibronectin.
3.Mutation analysis of the non-homologous end joining (NHEJ) protein associated with the repair of the double strand DNA breaks : Out of 14 multiple myeloma cell lines, one, one, and two harbored missense mutations of the Ku80, Ligase 4 and DNA-PKcs, in spite of the absence of mutation in Ku70 and XRCC4 genes. Since the remaining alleles kept the wild-type seguences, dominant-negative effect of the mutated proteins remains to be clarified further in myeloma cells.

Report

(4 results)
  • 2003 Annual Research Report   Final Research Report Summary
  • 2002 Annual Research Report
  • 2001 Annual Research Report
  • Research Products

    (30 results)

All Other

All Publications (30 results)

  • [Publications] Hatzivassiliou G, et al.: "IRTA1 and IRTA2, novel Immunoglobulin Superfamily Receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B cell malignancy."Immunity. 14(3). 277-289 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Hanamura I et al.: "Ectopic expression of MAFB gene in human myeloma cells carrying (14;20)(q32;q11) chromosomal translocations."Jpn J Cancer Res. 92. 638-644 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Tamura A et al.: "Interphase detection of immunoglobulin heavy chain translocations with specific oncogene loci in 173 patients with B-cell lymphoma."Cancer Genet Cytogenet. 129. 1-9 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Kato M et al.: "Lack of Ku80 alteration in multiple myeloma."Jpn J Cancer Res. 93. 359-362 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Ito M et al.: "MUM1/IRF4 expression is an unfavorable prognostic factor in B-cell chronic lymphocytic leukemia/ small lymphocytic lymphoma (SLL)."Jpn J Cancer Res. 93. 685-694 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Miura K et al.: "Frequent Occurrence of CCND1 Deregulation in Patients with Early Stages of Plasma Cell Dyscrasia."Cancer Sci. 94(4). 350-354 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Hayami Y et al.: "Inactivation of the E3/LAPTm5 gene by chromosomal rearrangements and DNA methylation in human multiple myeloma."Leukemia. 17(8). 1650-1657 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Ohbayashi K et al.: "A xeno-transplantable plasma cell leukemia cell line with a split translocation of the IgH gene."Cancer Genet Cytogenet. 144(1). 31-35 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Iida S et al.: "Multistep tumorigenesis of multiple myeloma: Its molecular delineation."Int J Hematol. 77. 207-212 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Hatzivassiliou G, Miller I, Takizawa J, Rao PH, Palanisamy N, Iida S, Tagawa S, Russo JJ, Mendelsohn C, Clynes R, Neri A, Chaganti RSK., Dalla-Favera R: "IRTA1 and IRTA2, novel Immunoglobulin Superfamily Receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B cell malignancy."Immunity. 14(3). 277-289 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Hanamura I, Iida S, Akano Y, Hayami Y, Kato M, Miura K, Harada S, Banno S, Wakita A, Kiyoi H, Naoe T, Shimizu S, Sonta S, Nitta M, Taniwaki M, Ueda R: "Ectopic expression of MAFB gene in human myeloma cells carrying (14;20)(q32;q11) chromosomal translocations."Japanese Journal of Cancer Research. 92. 638-644 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Tamura A, Miura I, Iida S, Yokota S, Horiike S, Nishida K, Fujii H, Nakamura S, Seto M, Ueda R, Taniwaki, M.: "Interphase detection of immunoglobulin heavy chain translocations with specific oncogene loci in 173 patients with B-cell lymphoma."Cancer Genet Cytogenet. 129. 1-9 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Kato M, Iida S, Komatsu H, Ueda R: "Lack of Ku80 alteration in multiple myeloma."Japanese Journal of Cancer Research. 93. 359-362 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Ito M, Iida S, Inagaki H, Tsuboi K, Komatsu H, Yamaguchi M, Nakamura N, Suzuki R, Seto M, Nakamura S, Morishima Y, Ueda R: "MUM1/IRF4 expression is an unfavorable prognostic factor in B-cell chronic lymphocytic leukemia/ small lymphocytic lymphoma (SLL)."Japanese Journal of Cancer Research. 93. 685-694 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Miura K, Iida S, Hanamura I, Kato M, Banno S, Ishida T, Kusumoto, S, Takeuchi G, Miwa H, Nitta M, Inagaki H, Eimoto T, Nomura K, Taniwaki N, Ueda R.: "Frequent Occurrence of CCND1 Deregulation in Patients with Early Stages of Plasma Cell Dyscrasia."Cancer Science. 94(4). 350-354 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Hayami Y, Iida S, Nakazawa N, Hanamura I, Kato M, Komatsu H, Miura I, Dave BJ, Sanger WG, Lim B, Taniwaki M, Ueda R.: "Inactivation of the E3/LAPTm5 gene by chromosomal rearrangements and DNA methylation in human multiple myeloma."Leukemia. 17(8). 1650-1657 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Ohbayashi K, Taniwaki M, Ninomiya M, Kiyoi H, Iida S, Ueda R, Naoe T.: "A xeno-transplantable plasma cell leukemia cell line with a split translocation of the IgH gene."Cancer Genet Cytogenet. 144(1). 31-35 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Iida S, Ueda R.: "Multistep tumorigenesis of multiple myeloma : Its molecular delineation."International Journal of Hematology. 77. 207-212 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Kato M, Iida S, et al.: "Lack of Ku80 alteration in multiple myeloma"Jpn J Cancer Res. 93. 359-362 (2002)

    • Related Report
      2003 Annual Research Report
  • [Publications] Miura K, Iida S, et al.: "Frequent occurrence of CCND1 deregulation in patients with early stages of plasma cell dyscrasia."Cancer Sci. 94(4). 350-354 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Hayami Y, Iida S, et al.: "Inactivation of the E3/LAPTm5 gene by chromosomal rearrangement and DNA methylation in human multiple myeloma."Leukemia. 17(8). 1650-1657 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Ohbayashi K, Iida S, et al.: "A xeno transplantable plasma cell leukemia cell line with split translocation of the IgH gene."Cancer Genet Cytogenet. 144(1). 31-35 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Iida S, Ueda R: "Multistep tumorigenesis of multiple myeloma : Its molecular delineation"Int J Hematal. 77. 207-212 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Miura K, Iida S, et al.: "Frequent Occurrence of CCND1 Deregulation in Patients with Early Stages of Plasma Cell Dyscrasia"Cancer Science. 94・4(in press). (2003)

    • Related Report
      2002 Annual Research Report
  • [Publications] Kato M, Iida S, et al.: "Lack of Ku80 Alteration in multiple myeloma"Japanese Journal of Cancer Research. 93・5. 359-362 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Ito M, Iida S, et al.: "MUM1/IRE4 Expression is An Unfavorable Prognostic Footer in B-CLL/SLL"Japanese Journal of Cancer Research. 93・6. 685-694 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Butler M, Iida S, et al.: "Alternative translocation Breakpoint Cluster Region S' to BCL-6 in B-cell Non-Hodgkin's Lymphoma"Cancer Research. 62. 4089-4094 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Hanamura I, Iida S, et al.: "Ectopic expression of MAFB gene in human myelomu cells carrying (14;20)(g32;g11) chronusomal translocations"Jpn. J. Cancer. Res.. 92. 638-644 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Hatzivassiliou G, Iida S, et al.: "IRTA1 and IRTA2, novel immunogiobulin superfamily receptors expresend in B cells and involeal in chromosome lg21 abnovmalities in B cell malignancy"Immunity. 14. 277-289 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Tomuro A, Iida S, et al.: "Interphase detection of immunoglobulin heavy chain translocations with speafe oncogene loci in 173 patients with B cell lymphoince"Cancer Genet Cytogenet. 129(1). 1-9 (2001)

    • Related Report
      2001 Annual Research Report

URL: 

Published: 2001-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi